Printer Friendly

Articles from Chain Drug Review (October 26, 2015)

1-82 out of 82 article(s)
Title Author Type Words
ACA's impact good for people on Medicare. 259
Acquisition extends Teva's reach in Mexico. 645
Albertsons IPO is postponed. 366
ANI will buy two NDAs from Merck. 205
Apps promise to transform health care. 683
Arthritis Foundation, CVS expand alliance. 443
As the baby boomers age, drug chains stand to benefit. 439
Balance of power shifting toward South and West. 1285
Bratspies named chief merchant at Walmart. 446
Calif. allows substitution of biologics. 304
CDC: 2015 flu vaccine shows improvement. 131
CE catalog highlights. 202
Coty agrees to acquire digital marketing firm. 269
Despite headwinds, store network generates sales gain. 497
Diabetes combo treatment denied. 133
Drug chains double as technology innovators. 746
ECRM slates Convenience/Front End show. 200
Enrollment on health exchanges to grow slowly. 681
Excellence in pharmacy practice. 16215
FDA belatedly gears up to handle biosimilar applications. 625
Foley leaves Walgreens to join Fred's exec team. 436
For every weight problem there's a different solution. 377
Gaps in measurement hamper bid to improve quality. 373
Generics manufacturers keep up steady stream of launches. 522
Gillette launches major promotional effort. 304
GPhA bullish on Trans-Pacific partnership. 673
Health care partnerships the wave of the future. Woldt, Jeffrey 735
Health Mart town halls to focus on med sync. 299
Hi-Tech expands its sports nutrition portfolio. 298
Horizon expanding U.S. headquarters. Brief article 256
In-store flu shots catch on in Canada. 187
Investments in future to take a short-term toll on earnings. 397
Kantar Retail event sizes up omnichannel landscape. 311
Lilly acquires intranasal product. 132
Lilly move is new setback for drug class. 443
Little has been done to reduce vulnerability to cyberattacks. 484
Low blood glucose in newborns studied. 104
Managing kidney disease. Muzyk, Tara 909
MarketTrack analysis: diet. Brief article 269
MarketTrack analysis: vitamin supplements. 274
MCX: Mobile payments and more. 247
Medicare impasse arises. 574
Megamerger to create dominant force in beer market. 461
National Retail Federation. Brief article 133
New system enhances Rx service at Fruth. 378
Obesity epidemic reaches new heights of seriousness. 846
Partners harness power of Balance Rewards. 246
Pharmacists want distinguishable names for biologic therapies. 553
PhRMA decides on its next chief exec. 362
Quarterly profit increases less than 1% at Jean Coutu. Financial report 1030
Ranks of uninsured are declining. 464
Researchers aim to facilitate evidence-based decisions. Brief article 136
Retailers must adapt to nation's growing diversity. 1282
Rite Aid makes statement by rebuilding in Baltimore. 504
Rx chains help guide patients on ACA, Medicare. 488
Rx educators, students are honored. 217
Rx makes gains globally. 600
RxSchool live online CE. 196
Sandoz is seeking approval for version of Enbrel. 427
SDM loyalty program reaches milestone. 323
Settlement halts private label knockoffs of eos lip balm. 148
Shoppers want 'instant information'. 184
Signal. Brief article 124
Social media has impact on consumer health care. Moyer, Megan 779
Study eyes 'prescription opioid crisis'. 399
Study eyes pricing trends in generics sector. 837
Study finds mass retail advantages beat online. 786
Supplements first line of defense for joints. 377
Tamoxifen found to strengthen white blood cells. 317
Technology must be backbone of better health care. Coopman, Robert 479
Top 100 2015 CDR top 100 chain drug markets. 2817
Top branded drugs by prescriptions filled. Table 2382
Top PBM adds new drugs to its formulary. 559
Trials for obesity drug on hold. 152
Turning point in cancer care. 566
Valeant pricing under scrutiny. 105
Walmart offers health solutions. 633
Walmart understands times are changing. Pinto, David 592
Wearable massage device is rolled out by Wahl. 340
Wellness trend, VMS a perfect match. 413
When it comes to Rx, convenience a big factor. 1143
Workshop to explore quality ratings in Rx. 150

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters